Diagen is a Turkish startup that specializes in providing lab equipment and consultancy services in molecular biology and genetics. Established in 1998, the company aims to support the mission of diagnostic and preventive medicine. With a strong focus on preventive healthcare processes, Diagen has positioned itself in the industry through honest and ethical practices. The company has a specialized team in molecular biology and genetics and extends its services to strategic sectors such as veterinary medicine, environment, and food safety. With a commitment to quality and ethical standards, Diagen has implemented TSE-HYB in 2002 and ISO 9001:2008 quality standards in 2008. The company values the principle of "Family of DiaGen" and adopts a dynamic approach by closely following evolving technologies. Diagen envisions establishing a significant presence in the global market with its expert team and aims to be a leader in the market with a principle of continuous development and renewal. The mission of the company focuses on providing high-quality products and services to scientists, keeping pace with the developments in biotechnology to meet the needs and expectations of customers, and providing a quality living environment for employees and society. Operating in the fields of human, animal, food, and environmental health, Diagen's scope includes the design, development, production, supply, storage, marketing, sales, and after-sales services for research and diagnostic reagents. The startup operates in the sectors of Digital Health, Health Care, Health and Wellness, and Healthtech and is headquartered in Turkey. Currently, there is no publicly available information about Diagen's last investment or its investors.
There is no investment information
No recent news or press coverage available for Diagen Animal Health.